AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23421600 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine (ALC) 3 g/day with riluzole 100 mg/day
Number of subjects: 82
Study 23421600 — intervention group
Group type: COMPARATOR
Intervention: Placebo 3 g/day with riluzole 100 mg/day
Number of subjects: 82
Study 23421600 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine (ALC)
Number of subjects: 82
Study 23421600 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 16480789 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task training
Number of subjects: 0
Study 16480789 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 14732410 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagined self-rotations
Number of subjects: 0
Study 14732410 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagined self-translations
Number of subjects: 0
Study 14732410 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance information about the to-be-imagined perspective
Number of subjects: 0
Study 14732410 — intervention group
Group type: EXPERIMENTAL
Intervention: Both tasks (self-rotations and self-translations)
Number of subjects: 0
Study 10980908 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombotic therapies
Number of subjects: 0
Study 10980908 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary prevention strategies and risk factor modification
Number of subjects: 0
Study 9098093 — intervention group
Group type: EXPERIMENTAL
Intervention: Oil-based Q10 (90 mg/d)
Number of subjects: 60
Study 9098093 — intervention group
Group type: EXPERIMENTAL
Intervention: Granular Q10 (90 mg/d)
Number of subjects: 60
Study 9098093 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 9098093 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (Oil-based, Granular, Placebo)
Number of subjects: 60
Study 9098093 — intervention group
Group type: EXPERIMENTAL
Intervention: Oil-based and Granular Q10
Number of subjects: 60
Study 9098093 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg Q10 (single dose)
Number of subjects: 60
Study 8218955 — intervention group
Group type: EXPERIMENTAL
Intervention: Transnasal administration of butorphanol (2 mg)
Number of subjects: 0
Study 8218955 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual administration of butorphanol (2 mg)
Number of subjects: 0
Study 8218955 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal administration of butorphanol (2 mg)
Number of subjects: 0
Study 8218955 — intervention group
Group type: COMPARATOR
Intervention: Intravenous administration of butorphanol (2 mg)
Number of subjects: 0
Study 3700691 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 1,200 mg/d
Number of subjects: 12
Study 3700691 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg/d
Number of subjects: 12
Study 3700691 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30537626 — intervention group
Group type: EXPERIMENTAL
Intervention: Sticky mittens training (4-minute session with Velcro covered toys)
Number of subjects: 24
Study 30537626 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 24
Study 28743757 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 29
Study 28743757 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoiesis-stimulating agent (ESA) treatment
Number of subjects: 29
Study 28743757 — intervention group
Group type: COMPARATOR
Intervention: Baseline measurement
Number of subjects: 29
Study 26914029 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV nosode at 30C and 50C potencies
Number of subjects: 24
Study 25112372 — intervention group
Group type: EXPERIMENTAL
Intervention: Paricalcitol
Number of subjects: 57
Study 25112372 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfacalcidol
Number of subjects: 57
Study 22269382 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening arm (PSA every 4 years, prostate biopsy when PSA ≥3 ng/ml)
Number of subjects: 4278
Study 22269382 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no tests)
Number of subjects: 4278
Study 19738493 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive patients
Number of subjects: 74
Study 17513813 — intervention group
Group type: EXPERIMENTAL
Intervention: Active specific immunotherapy with allogeneic melanoma lysates and low-dose interferon alfa-2b (IFN-alpha-2b) for 2 years
Number of subjects: 604
Study 17513813 — intervention group
Group type: COMPARATOR
Intervention: High-dose interferon alfa-2b for 1 year
Number of subjects: 604
Study 14966348 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 Gy fractions (group A)
Number of subjects: 46
Study 14966348 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 Gy fractions (group B)
Number of subjects: 46
Study 12243812 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiation with concomitant and maintenance chemotherapy (96% of patients)
Number of subjects: 2551
Study 9659245 — intervention group
Group type: EXPERIMENTAL
Intervention: Throat swabs
Number of subjects: 50
Study 9659245 — intervention group
Group type: EXPERIMENTAL
Intervention: Sputum specimens
Number of subjects: 50
Study 9659245 — intervention group
Group type: EXPERIMENTAL
Intervention: Both specimens (throat swab and sputum)
Number of subjects: 50
Study 9659245 — intervention group
Group type: COMPARATOR
Intervention: Overall detection
Number of subjects: 50
Study 9659245 — intervention group
Group type: COMPARATOR
Intervention: Paired specimens
Number of subjects: 50
Study 8586126 — intervention group
Group type: EXPERIMENTAL
Intervention: OKY-046 (400 mg/day)
Number of subjects: 0
Study 2765345 — intervention group
Group type: EXPERIMENTAL
Intervention: Priming with alcuronium
Number of subjects: 0
Study 2765345 — intervention group
Group type: EXPERIMENTAL
Intervention: Priming with tubocurarine
Number of subjects: 0
Study 2765345 — intervention group
Group type: COMPARATOR
Intervention: Control (no priming)
Number of subjects: 0
Study 823084 — intervention group
Group type: EXPERIMENTAL
Intervention: Butalamine hydrochloride (3 X 2 tablets daily)
Number of subjects: 19
Study 823084 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 31462137 — intervention group
Group type: EXPERIMENTAL
Intervention: NLR ≥ 5
Number of subjects: 1102
Study 31462137 — intervention group
Group type: EXPERIMENTAL
Intervention: Adding NLR to MSKCC variables
Number of subjects: 1102
Study 31462137 — intervention group
Group type: EXPERIMENTAL
Intervention: Adding NLR among patients who died before 24 months (N=415)
Number of subjects: 1102
Study 31462137 — intervention group
Group type: EXPERIMENTAL
Intervention: Adding NLR among those alive at 24 months (N=636)
Number of subjects: 1102
Study 31462137 — intervention group
Group type: EXPERIMENTAL
Intervention: NLR with IMDC variables
Number of subjects: 1102
Study 30600173 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered acupressure
Number of subjects: 76
Study 30600173 — intervention group
Group type: COMPARATOR
Intervention: Sham acupressure
Number of subjects: 76
Study 28335837 — intervention group
Group type: EXPERIMENTAL
Intervention: Potent P2Y12 inhibitors (prasugrel, ticagrelor, intravenous cangrelor)
Number of subjects: 87640
Study 28335837 — intervention group
Group type: EXPERIMENTAL
Intervention: Potent P2Y12 inhibitors
Number of subjects: 87640
Study 24799153 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 0
Study 24799153 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 0
Study 24799153 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study 23865839 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 76
Study 23865839 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 21893645 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal kangaroo care (KC)
Number of subjects: 62
Study 21893645 — intervention group
Group type: COMPARATOR
Intervention: Paternal kangaroo care (KC)
Number of subjects: 62
Study 19744976 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative studies conducted alongside randomised controlled trials
Number of subjects: 100
Study 19744976 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative studies conducted before the trial
Number of subjects: 100
Study 19744976 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative studies conducted during the trial
Number of subjects: 100
Study 19744976 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative studies conducted after the trial
Number of subjects: 100
Study 19744976 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of qualitative and quantitative findings
Number of subjects: 100
Study 19744976 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of qualitative studies
Number of subjects: 100
Study 17102667 — intervention group
Group type: EXPERIMENTAL
Intervention: First eye surgery
Number of subjects: 50
Study 17102667 — intervention group
Group type: COMPARATOR
Intervention: Second eye surgery
Number of subjects: 50
Study 17102667 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser ablation for both eyes
Number of subjects: 50
Study 17102667 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative period for both eyes
Number of subjects: 50
Study 15143715 — intervention group
Group type: EXPERIMENTAL
Intervention: Yinchenghao decoction (YCHD)
Number of subjects: 60
Study 15143715 — intervention group
Group type: EXPERIMENTAL
Intervention: S-adenosy-L-methionine (SAM)
Number of subjects: 60
Study 11371893 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate cystoscopy
Number of subjects: 100
Study 11371893 — intervention group
Group type: COMPARATOR
Intervention: Delayed cystoscopy
Number of subjects: 100
Study 9209184 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate supplementation (0.75 L carbohydrate beverage, 0.25 L every 15 min during running)
Number of subjects: 30
Study 9209184 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.75 L placebo beverage, 0.25 L every 15 min during running)
Number of subjects: 30
Study 8094467 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxol (250 mg/m2 by 24-hour intravenous infusion every 3 weeks)
Number of subjects: 119
Study 8094467 — intervention group
Group type: EXPERIMENTAL
Intervention: Merbarone (1000 mg/m2 by continuous intravenous infusion daily for 5 days every 3 weeks)
Number of subjects: 119
Study 8094467 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxantrone (150 mg/m2 by intravenous infusion over 1 hour every 3 weeks)
Number of subjects: 119
Study 2887097 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 338
Study 2887097 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 338
Study 2887097 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Nifedipine and Metoprolol
Number of subjects: 338
Study 2887097 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (in patients already receiving beta blockers)
Number of subjects: 338
Study 31620860 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiology taping (KT) 50% stretch
Number of subjects: 23
Study 31620860 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiology taping (KT) 80% stretch
Number of subjects: 23
Study 31620860 — intervention group
Group type: COMPARATOR
Intervention: Normal swallowing (without KT)
Number of subjects: 23
Study 29504207 — intervention group
Group type: EXPERIMENTAL
Intervention: HIT-enhanced SMBG
Number of subjects: 128
Study 29504207 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-centered goal setting
Number of subjects: 128
Study 29504207 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined approach (HIT-enhanced SMBG + family-centered goal setting)
Number of subjects: 128
Study 29504207 — intervention group
Group type: COMPARATOR
Intervention: Combined approach vs HIT-enhanced SMBG
Number of subjects: 128
Study 29504207 — intervention group
Group type: COMPARATOR
Intervention: Combined approach vs Family-centered goal setting
Number of subjects: 128
Study 27333620 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone combined with rhTPO
Number of subjects: 48
Study 27333620 — intervention group
Group type: COMPARATOR
Intervention: Single high-dose dexamethasone
Number of subjects: 48
Study 25192026 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg Zn/day (experimental group)
Number of subjects: 30
Study 25192026 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 30
Study 21283046 — intervention group
Group type: EXPERIMENTAL
Intervention: Interrupted sedation protocol (midazolam bolus of 0.1 mg/kg, followed by infusion with daily interruption)
Number of subjects: 102
Study 21283046 — intervention group
Group type: COMPARATOR
Intervention: Continuous sedation protocol (midazolam bolus of 0.1 mg/kg, followed by continuous infusion)
Number of subjects: 102
Study 20354006 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 1% infiltration
Number of subjects: 12
Study 20354006 — intervention group
Group type: COMPARATOR
Intervention: Saline infiltration (control)
Number of subjects: 12
Study 18764823 — intervention group
Group type: EXPERIMENTAL
Intervention: Washed blood (Group A)
Number of subjects: 0
Study 18764823 — intervention group
Group type: COMPARATOR
Intervention: Unwashed blood (Group B)
Number of subjects: 0
Study 15972728 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim 300 mg daily for three days
Number of subjects: 59
Study 15972728 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 15972728 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim
Number of subjects: 59
Study 12579169 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol/dorzolamide fixed combination
Number of subjects: 65
Study 12579169 — intervention group
Group type: COMPARATOR
Intervention: Latanoprost 0.005%
Number of subjects: 65
Study 11116505 — intervention group
Group type: EXPERIMENTAL
Intervention: Central corneal thickness measurement
Number of subjects: 98
Study 11116505 — intervention group
Group type: EXPERIMENTAL
Intervention: Correction factor for corneal thickness
Number of subjects: 98
Study 8621129 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnant women (second trimester)
Number of subjects: 103
Study 8621129 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnant women (all trimesters)
Number of subjects: 103
Study 8621129 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnant women (second and third trimesters)
Number of subjects: 103
Study 8621129 — intervention group
Group type: COMPARATOR
Intervention: Controls (age-matched nonpregnant women)
Number of subjects: 103
Study 8621129 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnant women (third trimester)
Number of subjects: 103
Study 1624646 — intervention group
Group type: EXPERIMENTAL
Intervention: Lofepramine
Number of subjects: 79
Study 1624646 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 79
Study 1624646 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 1624646 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 79
Study 6095664 — intervention group
Group type: EXPERIMENTAL
Intervention: Today contraceptive sponge
Number of subjects: 0
Study 6095664 — intervention group
Group type: COMPARATOR
Intervention: Diaphragm with spermicide
Number of subjects: 0
Study 31243692 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training (Rex group, n=30)
Number of subjects: 60
Study 31243692 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training with compression garment (Rex-Com group, n=30)
Number of subjects: 60
Study 31278509 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal Targeting System (DTS)
Number of subjects: 36
Study 31278509 — intervention group
Group type: COMPARATOR
Intervention: Free-hand fluoroscopic guidance
Number of subjects: 36
Study 28870208 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Top Tips (10TT)
Number of subjects: 537
Study 28870208 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 537
Study 26065353 — intervention group
Group type: EXPERIMENTAL
Intervention: Bandage contact lenses
Number of subjects: 32
Study 26065353 — intervention group
Group type: COMPARATOR
Intervention: Pressure patching
Number of subjects: 32
Study 23819991 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated Neuropsychological Assessment Metrics 4 (ANAM4)
Number of subjects: 419
Study 23819991 — intervention group
Group type: EXPERIMENTAL
Intervention: CNS‐Vital Signs
Number of subjects: 419
Study 23819991 — intervention group
Group type: EXPERIMENTAL
Intervention: CogState
Number of subjects: 419
Study 23819991 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Post‐Concussion Assessment and Cognitive Test (ImPACT)
Number of subjects: 419
Study 21780543 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol 50 microg
Number of subjects: 210
Study 21780543 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol 25 microg
Number of subjects: 210
Study 21780543 — intervention group
Group type: COMPARATOR
Intervention: Intracervical dinoprostone 0.5 mg
Number of subjects: 210
Study 19454622 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive shoulder abduction loading intervention for 8 weeks
Number of subjects: 14
Study 19454622 — intervention group
Group type: COMPARATOR
Intervention: Control group with weight of the arm supported during reaching tasks
Number of subjects: 14
Study 16916334 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (100 mg b.i.d.)
Number of subjects: 110
Study 16916334 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 12776806 — intervention group
Group type: EXPERIMENTAL
Intervention: Test cyclosporine non-SMEDDS formulation
Number of subjects: 24
Study 12776806 — intervention group
Group type: COMPARATOR
Intervention: Cyclopsorine SMEDDS formulation
Number of subjects: 24
Study 9887161 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate (3 g [1200 mg of elemental calcium] daily)
Number of subjects: 930
Study 9887161 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 930
Study 7536831 — intervention group
Group type: EXPERIMENTAL
Intervention: Atole (163 kcal/682 kJ, 11.5 g protein per cup)
Number of subjects: 0
Study 7536831 — intervention group
Group type: COMPARATOR
Intervention: Fresco (59 kcal/247 kJ, 0 g protein per cup)
Number of subjects: 0
Study 7536831 — intervention group
Group type: EXPERIMENTAL
Intervention: Atole
Number of subjects: 0
Study 7536831 — intervention group
Group type: COMPARATOR
Intervention: Fresco
Number of subjects: 0
Study 2109473 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil 1 mg
Number of subjects: 24
Study 2109473 — intervention group
Group type: COMPARATOR
Intervention: Control (spontaneous awakening)
Number of subjects: 24
Study 2109473 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil 1 mg (Group B)
Number of subjects: 24
Study 6993588 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzathine penicillin G treatment
Number of subjects: 194
Study 6849740 — intervention group
Group type: EXPERIMENTAL
Intervention: Alinidine 80 mg
Number of subjects: 5
Study 6849740 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg
Number of subjects: 5
Study 6849740 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydralazine 50 mg
Number of subjects: 5
Study 6849740 — intervention group
Group type: EXPERIMENTAL
Intervention: Alinidine 80 mg combined with Hydralazine 50 mg
Number of subjects: 5
Study 6849740 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg combined with Hydralazine 50 mg
Number of subjects: 5
Study 6849740 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 31706311 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein shake (PS)
Number of subjects: 0
Study 31706311 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate shake (CS)
Number of subjects: 0
Study 29419709 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session, clinic-based intervention promoting condom use
Number of subjects: 600
Study 27810043 — intervention group
Group type: EXPERIMENTAL
Intervention: S-ICD
Number of subjects: 140
Study 27810043 — intervention group
Group type: COMPARATOR
Intervention: TV-ICD
Number of subjects: 140
Study 25377588 — intervention group
Group type: EXPERIMENTAL
Intervention: SASA! intervention
Number of subjects: 0
Study 22536858 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard topical lidocaine‐4% cream and 99mTc‐sulfur colloid injection
Number of subjects: 140
Study 22536858 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo cream and 99mTc‐sulfur colloid injection containing NaHCO3
Number of subjects: 140
Study 22536858 — intervention group
Group type: COMPARATOR
Intervention: All African Americans
Number of subjects: 140
Study 20074196 — intervention group
Group type: EXPERIMENTAL
Intervention: Audit and Feedback (A/F) intervention
Number of subjects: 192
Study 20074196 — intervention group
Group type: COMPARATOR
Intervention: Control group (no A/F intervention)
Number of subjects: 192
Study 18823195 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-dimensional maze navigation training
Number of subjects: 0
Study 16075192 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent training group
Number of subjects: 0
Study 16075192 — intervention group
Group type: COMPARATOR
Intervention: General project participation
Number of subjects: 0
Study 16075192 — intervention group
Group type: COMPARATOR
Intervention: Declining families
Number of subjects: 0
Study 16075192 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents accepting the offer of parent training
Number of subjects: 0
Study 16075192 — intervention group
Group type: COMPARATOR
Intervention: Parents from disadvantaged areas
Number of subjects: 0
Study 16075192 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents with children having higher levels of behavior problems
Number of subjects: 0
Study 12609569 — intervention group
Group type: EXPERIMENTAL
Intervention: Univariate analysis of all patients
Number of subjects: 436
Study 12609569 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate Cox model
Number of subjects: 436
Study 12609569 — intervention group
Group type: EXPERIMENTAL
Intervention: Subset multivariate analyses for limited-stage disease (LD-SCLC)
Number of subjects: 436